Zoledronic Acid

CAS 118072-93-8 22 API suppliersSmall Molecule

Overview

Zoledronic acid is a bisphosphonate drug used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. It works by inhibiting the activity of osteoclasts, cells that break down bone tissue.

API suppliers (22)

Suppliers of Zoledronic Acid evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India7United Kingdom2Argentina2Netherlands1Italy1Taiwan1USA1United States1

Country recorded for 17 of 22 suppliers.

10 of 22 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (26 approved US products), the latest listed US patent on Zoledronic Acid expires 5 Aug 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
thiolane 1,1-dioxide
Canonical SMILES
C1CCS(=O)(=O)C1
InChIKey
HXJUTPCZVOIRIF-UHFFFAOYSA-N

Therapeutic areas

OncologyOsteoporosisMetabolic Bone Diseases
Verified Supplier Partner

Do you supply Zoledronic Acid? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.